FDA CLEARS NEXT-GENERATION SURGIMAP 2.0 SOFTWARE.

NEMARIS Inc.; UNITED States. Food & Drug Administration; COMPUTING platforms; MEDICREA (Company); PROFITABILITY

The article focuses on the 510(k) clearance received from the U.S. Food and Drug Administration (FDA) by Nemaris Inc., a software company, for the next-generation SURGIMAP 2.0 platform software. Topics include the features and use of the SURGIMAP 2.0, the development of the UNid plug in by MEDICREA, a developer of surgical technologies, and the profitability of the company in 2014.